Glioma Glioblastoma Multiforme trials recruiting in District of Columbia

Fewer than 3 recruiting trials found.

All Glioma Glioblastoma Multiforme trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
  NCT06810544 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.